We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+12.13%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$32.7B
AUM Growth
+$651M
(+2%)
Cap. Flow
-$2.75B
Cap. Flow
% of AUM
-8.41%
Top 10 Holdings %
Top 10 Hldgs %
20.41%
Holding
1,997
New
181
Increased
978
Reduced
793
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$146M |
| 2 |
Albemarle
ALB
|
+$38M |
| 3 |
McCormick & Company Non-Voting
MKC
|
+$32.7M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$30.8M |
| 5 |
J.M. Smucker
SJM
|
+$26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$420M |
| 2 |
Microsoft
MSFT
|
+$382M |
| 3 |
Amazon
AMZN
|
+$209M |
| 4 |
NVIDIA
NVDA
|
+$163M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.56% |
| 2 | Industrials | 12.61% |
| 3 | Consumer Staples | 11.87% |
| 4 | Financials | 10.22% |
| 5 | Consumer Discretionary | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
SKYX Platforms
SKYX
$165M
| $16.6K | ﹤0.01% |
+10,374
| New | +$16.1K |
|
|
TWOU
1927
DELISTED
2U Inc
TWOU
| $16.3K | ﹤0.01% |
442
+99
| +29% | +$4.83K |
|
1928
Karyopharm Therapeutics
KPTI
$148M
| $16.2K | ﹤0.01% |
1,250
-229
| -15% | -$3.09K |
|
|
ORGN
1929
DELISTED
Origin Materials
ORGN
| $16.2K | ﹤0.01% |
645
+139
| +27% | +$3.98K |
|
|
ASRT
1930
DELISTED
Assertio
ASRT
| $15.7K | ﹤0.01% |
979
+210
| +27% | +$5.19K |
|
|
OPTN
1931
DELISTED
OptiNose
OPTN
| $15.6K | ﹤0.01% |
804
-317
| -28% | -$5.79K |
|
1932
Citius Pharmaceuticals
CTXR
$13.1M
| $15.4K | ﹤0.01% |
814
+175
| +27% | +$3.32K |
|
1933
AtaiBeckley Inc
ATAI
$2.66B
| $15K | ﹤0.01% |
10,607
-246
| -2% | -$306 |
|
|
DNMR
1934
DELISTED
Danimer Scientific, Inc.
DNMR
| $14.8K | ﹤0.01% |
363
+78
| +27% | +$4.24K |
|
1935
374Water
SCWO
$36M
| $14.5K | ﹤0.01% |
+1,021
| New | +$13.6K |
|
|
KYNB
1936
Kyntra Bio
KYNB
$29M
| $13.5K | ﹤0.01% |
611
-118
| -16% | -$1.78K |
|
|
SGMO
1937
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $13.5K | ﹤0.01% |
24,902
-5,416
| -18% | -$2.5K |
|
|
LICY
1938
DELISTED
Li-Cycle Holdings Corp.
LICY
| $13.5K | ﹤0.01% |
2,885
+644
| +29% | +$7.31K |
|
1939
Cartesian Therapeutics
RNAC
$244M
| $13.4K | ﹤0.01% |
648
-189
| -23% | -$5.64K |
|
1940
Workhorse Group
WKHS
$30.4M
| $12.3K | ﹤0.01% |
11
+3
| +38% | +$3.59K |
|
|
KZR
1941
DELISTED
Kezar Life Sciences
KZR
| $11.2K | ﹤0.01% |
1,181
-221
| -16% | -$1.94K |
|
1942
Outlook Therapeutics
OTLK
$210M
| $10.3K | ﹤0.01% |
1,302
+294
| +29% | +$2.49K |
|
|
AEVA
1943
Aeva Technologies
AEVA
$1.1B
| $10.1K | ﹤0.01% |
2,666
+601
| +29% | +$1.92K |
|
|
AKTS
1944
DELISTED
Akoustis Technologies Inc
AKTS
| $9.65K | ﹤0.01% |
+11,573
| New | +$7.78K |
|
|
TIO
1945
DELISTED
Tingo Group, Inc. Common Stock
TIO
| $9.38K | ﹤0.01% |
13,593
-2,273
| -14% | -$1.83K |
|
1946
Atara Biotherapeutics
ATRA
$75.5M
| $8.22K | ﹤0.01% |
641
-127
| -17% | -$2.96K |
|
1947
FTC Solar
FTCI
$61.9M
| $7.76K | ﹤0.01% |
1,120
-6,199
| -85% | -$56.3K |
|
|
CMAX
1948
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $6.2K | ﹤0.01% |
+415
| New | +$17.2K |
|
|
RBOT
1949
DELISTED
Vicarious Surgical
RBOT
| $6.07K | ﹤0.01% |
+552
| New | +$6.15K |
|
|
VLD
1950
DELISTED
Velo3D, Inc.
VLD
| $5.99K | ﹤0.01% |
430
+100
| +30% | +$3.85K |
|
Similar funds
ProShare Advisors's Q4 2023 Portfolio in Review
As of Q4 2023, ProShare Advisors held 1,997 positions worth $32.7B, up 2% from $32.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
ProShare Advisors withdrew a net $2.75B in Q4 2023, closing 44 positions and reducing 793 holdings. Its most notable exit was Seagen Inc. Common Stock, an estimated $40.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Industrials and Consumer Staples.
Against the trend, ProShare Advisors opened a new position in DoorDash worth $28.6M.
- ProShare Advisors's largest Q4 2023 buy was DoorDash: 289,583 shares worth $28.6M.
- ProShare Advisors added most to Kenvue in Q4 2023, an estimated $146M increase.
- ProShare Advisors's biggest Q4 2023 reduction was Apple, cutting an estimated $420M.
- ProShare Advisors fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $40.1M.
- ProShare Advisors's ten largest holdings make up 20% of its $32.7B portfolio in Q4 2023.
- ProShare Advisors opened 181 new positions and closed 44 in Q4 2023.
- ProShare Advisors's portfolio value rose 2% quarter-over-quarter to $32.7B.
Based on ProShare Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.